Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. CMC Enterprise Pharmacy
WARNING LETTER
•CMC Enterprise Pharmacy•March 22, 2019

CMC Enterprise Pharmacy – FDA Warning Letter, Mar 22, 2019

Record Details

On June 4, 2020, the FDA issued a Warning Letter to CMC Enterprise Pharmacy following an inspection from March 18-22, 2019, which revealed serious deficiencies in sterile drug production. The firm received a Form FDA 483 on March 22, 2019, and responded on April 5, 2019. CMC Enterprise Pharmacy voluntarily ceased production of sterile and non-sterile drugs on April 11, 2019, and initiated a recall of all in-expiry sterile drug products.

The FDA found that drug products intended to be sterile were prepared, packed, or held under insanitary conditions, rendering them adulterated under section 501(a)(2)(A) of the FDCA. Violations included: non-laminar airflow, un-evaluated HEPA filters, dirty and particle-generating surfaces in the ISO 5 IV room, inadequate sporicidal agent use, improper personnel gowning and aseptic technique (exposed skin/hair, blocking first air, rapid movement, touching gowns with sterile gloves), poor facility design for material/personnel flow, inadequate material disinfection, lack of controls to prevent lower quality air influx, media fills not performed under challenging conditions, and surface sampling conducted post-cleaning, yielding unrepresentative results.

The FDA acknowledged the firm's cessation of operations as addressing immediate concerns. If CMC Enterprise Pharmacy resumes sterile drug production,

Company
CMC Enterprise Pharmacy
Inspection date
March 22, 2019
Product type
Tobacco
Office
Center for Tobacco Products
People
  • Monica R. Maxwell (Program Division Director)
  • Kevin Isaacs
  • Ken D. Haynes
View Company Profile

ID · b17a631d-c10c-472a-a6f8-4b1decd3bce3

Violation Codes6
21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(k)FD&C Act 503AFD&C Act 501(a)(2)(A)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for CMC Enterprise Pharmacy
  • 483 - 2019-03-22March 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CMC Enterprise Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.